|
?:abstract
|
-
Key Words: pediatric, nasotracheal intubation, videolaryngoscopy, COVID-19, SARS-CoV-2 The virus SARS-CoV-2 and the associated disease known as COVID-19 has been declared a global pandemic by the World Health Organization (WHO) According to the WHO, there are over 24 million confirmed cases of COVID-19 as of September 6th, 2020 1 Transmission occurs through aerosolization of large particles (droplets) in the air that eventually come into contact and contaminate a person or surface 2 Healthcare workers are at an increased risk of contracting SARS-CoV-2 while caring for infected patients, especially during aerosolizing procedures such as endotracheal intubation and mask ventilation 2 Additionally, this virus is known to have a long prodromal phase of up to 5 days during which the virus can be transmitted in the absence of symptoms 3 The American Association of Nurse Anesthetists (AANA) and the Anesthesia Patient Safety Foundation (APSF) have released recommendations on management of the patient with COVID19 A standard surgical mask is estimated to provide droplet and contact protection within 1-2 meters from patient 5 The N95 designation is obtained when the mask is tested and demonstrates blocking at least 95% of solid and liquid aerosol test particles 5 Due to the highly contagious nature of this disease and frequent exposure of operating room staff to aerosolizing procedures, airborne precaution PPE is a necessary safety measure During this case report, videolaryngoscopy was performed once the ETT was advanced through the nasal turbinates and utilization of external cricoid pressure and pilot balloon inflation were utilized to move the ETT tip anteriorly out of the pyriform fossa and into the glottic aperture
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}